{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:19:39Z","timestamp":1790176779561,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.prostaglandins.2019.106399","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T03:25:10Z","timestamp":1573701910000},"page":"106399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Role of sphingolipids in the pathogenesis of intrahepatic cholestasis"],"prefix":"10.1016","volume":"147","author":[{"given":"Agnieszka","family":"Mikucka-Niczyporuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Pierzynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lemancewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-7560","authenticated-orcid":false,"given":"Przemyslaw","family":"Kosinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Charkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Knas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Kacerovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8055-0576","authenticated-orcid":false,"given":"Agnieszka","family":"Blachnio-Zabielska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Laudanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2019.106399_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajog.2014.07.026","article-title":"Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels","volume":"212","author":"Brouwers","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"August (8)","key":"10.1016\/j.prostaglandins.2019.106399_bib0010","article-title":"Intrahepatic Cholestasis of Pregnancy: A Case Study of the Rare Onset in the First Trimester","volume":"55","author":"Stulic","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0015","first-page":"667","article-title":"The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestation age","volume":"212","author":"Puljic","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0020","doi-asserted-by":"crossref","first-page":"e28343","DOI":"10.1371\/journal.pone.0028343","article-title":"Fetal outcomes in pregnancy complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort","volume":"7","author":"Rook","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-88-4-487","article-title":"Prevalence of intrahepatic cholestasis of pregnancy in Chile","volume":"88","author":"Reyes","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/AOG.0000000000000346","article-title":"Intrahepatic cholestasis of pregnancy","volume":"124","author":"Williamson","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1089\/jwh.2007.0158","article-title":"Intrahepatic cholestasis of pregnancy: review of the literature and evaluation of current evidence","volume":"16","author":"Saleh","year":"2007","journal-title":"J Womens Health"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1515\/jpm-2014-0089","article-title":"Fetal complications due to intrahepatic cholestasis of pregnancy","volume":"43","author":"\u0160imj\u00e1k","year":"2015","journal-title":"J Perinat Med"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.jp.7211545","article-title":"The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population","volume":"26","author":"Lee","year":"2006","journal-title":"J Perinatol"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-2008-1078756","article-title":"Pregnancy outcomes Turing an era of aggressive management for intrahepatic cholestasis of pregnancy","volume":"25","author":"Lee","year":"2008","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: Management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0060","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep.20336","article-title":"Intrahepatic cholestasis of pregnancy: Relationship between bile acid levels and fetal complication rates","volume":"40","author":"Glantz","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.placenta.2016.07.002","article-title":"Mitochondrial gene expression profiles are associated with intrahepatic cholestasis of pregnancy","volume":"45","author":"Mella","year":"2016","journal-title":"Placenta"},{"issue":"April (2)","key":"10.1016\/j.prostaglandins.2019.106399_bib0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clinre.2015.12.008","article-title":"The pathophysiology of intrahepatic cholestasis of pregnancy","volume":"40","author":"Dixon","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0075","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1515\/jpm-2014-0207","article-title":"Can routine laboratory parameters predict adverse pregnancy outcomes in intrahepatic cholestasis of pregnancy?","volume":"43","author":"Oztas","year":"2015","journal-title":"J Perinat Med"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0080","series-title":"Green-Top Guideline No. 43","author":"Royal College of Obstetricians & Gynaecologists. Obstetric Cholestasis","year":"2011"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0085","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1478-3231.2007.01475.x","article-title":"Sphingolipid signalling and liver diseases","volume":"27","author":"Mari","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0090","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.24193","article-title":"Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice","volume":"53","author":"Matsubara","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1515\/hsz-2014-0296","article-title":"Sphingolipids in liver injury, repair and regeneration","volume":"396","author":"Nojima","year":"2015","journal-title":"Biol Chem"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0105","doi-asserted-by":"crossref","first-page":"e0127732","DOI":"10.1371\/journal.pone.0127732","article-title":"Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome","volume":"10","author":"Charkiewicz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.advms.2015.09.006","article-title":"Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets","volume":"61","author":"B\u0142achnio-Zabielska","year":"2016","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0115","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/rcm.6216","article-title":"A liquid chromatography\/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans","volume":"26","author":"Blachnio-Zabielska","year":"2012","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/1471-0528.12174","article-title":"Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study","volume":"120","author":"Wikstr\u00f6m Shemer","year":"2013","journal-title":"BJOG"},{"issue":"10201","key":"10.1016\/j.prostaglandins.2019.106399_bib0125","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(19)31607-1","article-title":"Ursodeoxycholic acid for intrahepatic cholestasis in pregnancy","volume":"394","author":"Marschall","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0130","doi-asserted-by":"crossref","DOI":"10.1136\/eb-2013-101298","article-title":"Ursodeoxycholic acid for intrahepatic cholestasis of pregnancy: good for the mother, not bad for the baby","volume":"18","author":"Carey","year":"2013","journal-title":"Evid Based Med"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0135","first-page":"21","article-title":"UDCA and activity of exoglycosidases in liver, kidney and serum of stressed rats","volume":"3","author":"Kna\u015b","year":"2007","journal-title":"ExpClin Hepatology"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bcp.12480","article-title":"Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy","volume":"79","author":"Esti\u00fa","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"July","key":"10.1016\/j.prostaglandins.2019.106399_bib0145","article-title":"Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy","author":"Goossens","year":"2019","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/jmg.2004.026187","article-title":"Genetics of familial intrahepatic cholestasis syndromes","volume":"42","author":"Mil van","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1478-3231.2011.02666.x","article-title":"Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P\/EDG1 axis in hepatocellular carcinoma","volume":"32","author":"Bao","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2174\/187152011797655140","article-title":"Sphingolipid metabolism and leukemia: A potential for novel therapeutic approaches","volume":"11","author":"Burns","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0165","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc1411","article-title":"Biologically active sphingolipids in cancer pathogenesis and treatment","volume":"4","author":"Ogretmen","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0170","doi-asserted-by":"crossref","first-page":"E2606","DOI":"10.3390\/ijms18122606","article-title":"Plasma sphingolipids in acute pancreatitis","volume":"18","author":"Kono\u0144czuk","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0175","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","article-title":"Bioactive sphingolipids: Metabolism and function","volume":"50","author":"Bartke","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1388-1981(02)00341-4","article-title":"Sphingosine kinase, sphingosine-1-phosphate, and apoptosis","volume":"1585","author":"Maceyka","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0185","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2400","article-title":"The alliance of sphingosine-1-phosphate and its receptors in immunity","volume":"8","author":"Rivera","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0190","doi-asserted-by":"crossref","first-page":"E741","DOI":"10.3390\/ijms18040741","article-title":"Sphingosine-1-phosphate metabolism and its role in the development of inflammatory bowel disease","volume":"18","author":"Wollny","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0195","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/liv.12331","article-title":"Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease","volume":"34","author":"Kurek","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0200","doi-asserted-by":"crossref","first-page":"E211","DOI":"10.1152\/ajpendo.91014.2008","article-title":"Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome","volume":"297","author":"Yang","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1872-034X.2011.00934.x","article-title":"High fat diet induced hepatic steatosis and insulin resistance: role of dysregulated ceramide metabolism","volume":"42","author":"Longato","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2478\/v10039-009-0010-y","article-title":"Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding","volume":"54","author":"Wierzbicki","year":"2009","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-010-0409-6","article-title":"High fat diet induces ceramide and sphingomyelin formation in rat\u2019s liver nuclei","volume":"340","author":"Chocian","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1194\/jlr.R031278","article-title":"Sphingolipids: regulators of cross talk between apoptosis and autophagy","volume":"54","author":"Young","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.prostaglandins.2019.106399_bib0225","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.prostaglandins.2016.04.005","article-title":"Plasma C16-Cer levels are increase in patients with preterm labor","volume":"123","author":"Laudanski","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882319301509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882319301509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:01:14Z","timestamp":1761098474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882319301509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":45,"alternative-id":["S1098882319301509"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106399","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of sphingolipids in the pathogenesis of intrahepatic cholestasis","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106399"}}